Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The Pennsylvania-based drug distributor announced it would be buying OneOncology, a physician-led specialty service group in which it already owned a minority stake. The company said the acquisition will complement its "pharmaceutical-centric strategy."
Paxton says the “woke” EHR giant is intentionally making it harder for patients and families to access historical medical data, violating state law. Epic denies the allegation.
Mark Cuban's startup Cost Plus Drugs and insurer Humana are said to be working on a deal that would allow Medicare Advantage patients to buy drugs directly from manufacturers. The terms of the agreement—which Forbes reports is in its early stages—are still unknown.
The results were shown in multiple posts on X. A clinical trial to prove the safety and efficacy of Elon Musk's brain implant is ongoing, with 12 people currently using the devices.
The Atlanta Police Department has joined the NYPD, as a nationwide manhunt for the killer takes authorities to Georgia. The NYPD said they believe the suspect entered New York City by bus shortly before Thanksgiving.
After announcing it would place time limits on reimbursement for the time a patient is under anesthesia, Anthem Blue Cross Blue Shield has now denied it ever intended to make the change.
The NYPD is offering a $10,000 award for “information leading to an arrest and conviction.” No arrests have been made and the killer has yet to be identified.
Brian Thompson, 50, was walking in Midtown Manhattan toward the New York Hilton Hotel, where he was expected to attend his company’s annual investor conference. He was shot by an unknown gunman who fled the scene.